XML 49 R30.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share
12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Earnings Per Share
21. Earnings Per Share
The following tables set forth reconciliations of the basic and diluted earnings per share computations for the periods presented:
 
 
  
Years Ended December 31,
 
Basic Earnings/(Loss) per Share
  
2021
 
  
2020
 
  
2019
 
Net income/(loss)
   $ 49,797      $ (35,655    $ (10,425
Less: Income distributed to participating securities
     (2,168      (2,216      (2,163
Less: Undistributed income allocable to participating securities
     (3,378      —          —    
    
 
 
    
 
 
    
 
 
 
Net income/(loss) available to common stockholders – Basic EPS
   $ 44,251      $ (37,871    $ (12,588
Weighted average common shares (in thousands)
     143,847        148,682        151,823  
    
 
 
    
 
 
    
 
 
 
Basic income/(loss) per share
   $ 0.31      $ (0.25    $ (0.08
    
 
 
    
 
 
    
 
 
 
 
  
Years Ended December 31,
 
Diluted Earnings/(Loss) per Share
  
2021
 
  
2020
 
  
2019
 
Net income/(loss) available to common stockholders
   $ 44,251      $ (37,871    $ (12,588
Add back: Undistributed income allocable to participating securities
     3,378        —          —    
Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive
     (3,353      —          —    
    
 
 
    
 
 
    
 
 
 
Net income/(loss) available to common stockholders – Diluted EPS
   $ 44,276      $ (37,871    $ (12,588
    
 
 
    
 
 
    
 
 
 
Weighted Average Diluted Shares (in thousands
):
                          
Weighted average common shares
     143,847        148,682        151,823  
Dilutive effect of common stock equivalents, excluding participating securities
     1,208        —          —    
    
 
 
    
 
 
    
 
 
 
Weighted average diluted shares, excluding participating securities (in thousands)
     145,055        148,682        151,823  
    
 
 
    
 
 
    
 
 
 
Diluted income/(loss) per share
   $ 0.31      $ (0.25    $ (0.08
    
 
 
    
 
 
    
 
 
 
Diluted earnings /(loss) per share presented above is calculated using the
two-class
method as this method results in the lowest diluted earnings per share amount for common stock. Total antidilutive
non-participating
common stock equivalents were 132
,
 
315 and 166 during the years ended December 31, 2021, 2020 and 2019, respectively (shares herein are reported in thousands). During the years ended December 31, 2020 and 2019, there were no dilutive common stock equivalents as the Company reported a net loss for the period.
Potential common shares associated with the conversion option embedded in the Convertible Notes for the year ended December 31, 2021 were 1,186 (shares herein are reported in thousands). There were no potential common shares included in weighted average diluted shares for the year ended December 31, 2020 as the Company’s average stock price was lower than the conversion price.
The following table reconciles weighted average diluted shares as reported on the Company’s Consolidated Statements of Operations for the years ended December 31, 2021, 2020 and 2019, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above:
 
 
  
Years Ended December 31,
 
Reconciliation of Weighted Average Diluted Shares (in thousands)
  
2021
 
  
2020
 
 
2019
 
Weighted average diluted shares as disclosed on the Consolidated Statements of Operations
     161,263        148,682
(1)
 
    151,823
(1)
 
Less: Participating securities:
                         
Weighted average shares of common stock issuable upon conversion of the Preferred Shares (Note 13)
     (14,750      —         —    
Potentially dilutive restricted stock awards
     (1,458      —         —    
    
 
 
    
 
 
   
 
 
 
Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above
     145,055        148,682
(1)
 
    151,823
(1)
 
    
 
 
    
 
 
   
 
 
 
 
(1)
Excludes 15,122 and 15,002 participating securities for the years ended December 31, 2020 and 2019, respectively, as the Company reported a net loss for those periods. Also excludes 6 and 152 potentially dilutive common stock equivalents for the years ended December 31, 2020 and 2019, respectively, as the Company reported a net loss for those periods (shares herein are reported in thousands).